Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes

被引:78
|
作者
Fujisawa, Keiko [1 ]
Katakami, Naoto [1 ,2 ]
Kaneto, Hideaki [1 ]
Naka, Toyoko [1 ]
Takahara, Mitsuyoshi [1 ]
Sakamoto, Fumie [1 ]
Irie, Yoko [1 ]
Miyashita, Kazuyuki [1 ]
Kubo, Fumiyo [1 ]
Yasuda, Tetsuyuki [1 ]
Matsuoka, Taka-aki [1 ]
Shimomura, Iichiro [1 ]
机构
[1] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Dept Metab & Atherosclerosis, Grad Sch Med, Suita, Osaka 5650871, Japan
关键词
sRAGE; RAGE; Cardiovascular event; Atherosclerosis; Type; 2; diabetes; GLYCATION END-PRODUCTS; CORONARY-ARTERY-DISEASE; ENDPRODUCTS RAGE; RECEPTOR; ATHEROSCLEROSIS; ASSOCIATION; SRAGE; FORM;
D O I
10.1016/j.atherosclerosis.2013.01.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is still controversial whether circulating soluble form of receptor for AGE (sRAGE) is associated with atherosclerosis in diabetic patients. In this study, we enrolled 276 Japanese type 2 diabetic subjects without history of cardiovascular disease (CVD), assessed their baseline clinical and biochemical data including serum sRAGE levels, and prospectively evaluated the association between these parameters and CVD events. The median follow-up period was 5.6 years and there were 25 new CVD events. The tertile analysis showed that the risk for CVD events was higher as serum sRAGE levels were increased (p for trend = 0.046). A multivariate Cox proportional hazards regression analysis revealed that serum sRAGE levels were independently associated with CVD (HR per 1SD = 1.59, 95% CI 1.04-2.45, p = 0.034), even after adjusting for conventional coronary risk factors. In summary, elevated sRAGE levels were associated with the increased risk of CVD in Japanese type 2 diabetic subjects. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:425 / 428
页数:4
相关论文
共 50 条
  • [1] Soluble RAGE in type 2 diabetes: Association with oxidative stress
    Devangelio, Eleonora
    Santilli, Francesca
    Formoso, Gloria
    Ferroni, Patrizia
    Bucciarelli, Loredana
    Michetti, Noerni
    Clissa, Cristina
    Ciabattoni, Giovanni
    Consoli, Agostino
    Davi, Giovanni
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 (04) : 511 - 518
  • [2] Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients
    Katakami, Naoto
    Matsuhisa, Munehide
    Kaneto, Hideaki
    Matsuoka, Taka-Aki
    Sakamoto, Kenya
    Yasuda, Tetsuyuki
    Yamasaki, Yoshimitsu
    DIABETES & VASCULAR DISEASE RESEARCH, 2008, 5 (03) : 190 - 197
  • [3] Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
    Heier, Martin
    Margeirsdottir, Hanna Dis
    Gaarder, Mario
    Stensaeth, Knut Haakon
    Brunborg, Cathrine
    Torjesen, Peter Abusdal
    Seljeflot, Ingebjorg
    Hanssen, Kristian Folkvord
    Dahl-Jorgensen, Knut
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [4] Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study
    Sabbatinelli, Jacopo
    Castiglione, Stefania
    Macri, Federica
    Giuliani, Angelica
    Ramini, Deborah
    Vinci, Maria Cristina
    Tortato, Elena
    Bonfigli, Anna Rita
    Olivieri, Fabiola
    Raucci, Angela
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [5] Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes
    Katakami, Naoto
    Matsuhisa, Munehide
    Kaneto, Hideaki
    Matsuoka, Taka-aki
    Sakamoto, Ken'ya
    Yasuda, Tetsuyuki
    Umayahara, Yutaka
    Kosugi, Keisuke
    Yamasaki, Yoshimitsu
    ATHEROSCLEROSIS, 2009, 204 (01) : 288 - 292
  • [6] Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes
    Thomas, M. C.
    Soderlund, J.
    Lehto, M.
    Makinen, V. -P.
    Moran, J. L.
    Cooper, M. E.
    Forsblom, C.
    Groop, P. -H.
    DIABETOLOGIA, 2011, 54 (10) : 2669 - 2677
  • [7] Soluble RAGE and malondialdehyde in type I diabetes patients without chronic complications during the course of the disease
    Reis, Janice S.
    Veloso, Clara A.
    Volpe, Caroline M. O.
    Fernandes, Jamille S.
    Borges, Erica A.
    Isoni, Camila A.
    Dos Anjos, Paula M. F.
    Nogueira-Machado, Jose A.
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (04) : 309 - 314
  • [8] RAGE Gene Polymorphisms Are Associated with Circulating Levels of Endogenous Secretory RAGE but Not with Coronary Artery Disease in Chinese Patients with Type 2 Diabetes Mellitus
    Peng, Wen Hui
    Lu, Lin
    Wang, Ling Jie
    Yan, Xiao Xiang
    Chen, Qiu Jing
    Zhang, Qi
    Zhang, Rui Yan
    Shen, Wei Feng
    ARCHIVES OF MEDICAL RESEARCH, 2009, 40 (05) : 393 - 398
  • [9] Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes An Analysis From the CARDS Trial
    Colhoun, Helen M.
    Betteridge, D. John
    Durrington, Paul
    Hitman, Graham
    Neil, Andrew
    Livingstone, Shona
    Charlton-Menys, Valentine
    Bao, Weihang
    DeMicco, David A.
    Preston, Gregory M.
    Deshmukh, Harshal
    Tan, Kathryn
    Fuller, John H.
    DIABETES, 2011, 60 (09) : 2379 - 2385
  • [10] Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
    Sousa Vergara Palma, Catia Cristina Silva
    Lopes, Pablo Moura
    Clemente Silva, Eliete Leao
    da Matta Bevilaqua, Maria de Fatima
    Bomfim, Alfredo de Souza
    Gomes, Marilia Brito
    DIABETES METABOLIC SYNDROME AND OBESITY, 2020, 13 : 2505 - 2514